Gezer Gezer

Dr. Gezer Gezer


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
GGGezer Gezer
Gezer Gezer
HYHayriye M. Yalvaç
Hayriye M. Yalvaç
KGKübra Güngör
Kübra Güngör
IYİzZet Yücesoy
İzZet Yücesoy

1 March 2020 in International Journal of Gynecological Cancer
Verified
Journal Article
Closed access
PDF file
GGGezer Gezer
Gezer Gezer
SÖSeda Duman Öztürk
Seda Duman Öztürk
THTurkay Hekimsoy
Turkay Hekimsoy
ÇVÇiğdem Vural
Çiğdem Vural
SISerkan İşGören
Serkan İşGören
AÇAydın Çorakçı
Aydın Çorakçı
Objective To evaluate the relationship between pelvic/para-aortic sentinel lymph node status and two different injection sites of 99m-technetium (99mTc)-labeled phytate in patients with endometrial cancer. Methods This was a randomized controlled trial involving 81 patients with endometrial cancer. In the cervical group (n=40), injections of 99mTc were performed at the 3 and 9 o’clock positions of the uterine cervix. In the endometrial group (n=41), 99mTc was injected into the fundal endometrium using a transcervical catheter. Sentinel lymph nodes were detected through pre-operative lymphoscintigraphy and intra-operatively using a handheld gamma probe. All patients underwent complete pelvic and para-aortic lymphadenectomy procedures. Pathologic ultra-staging was performed with immunostaining for cytokeratin in sentinel lymph nodes after routine hematoxylin and eosin histological examinations. The primary endpoint was the estimation of detection rates, sensitivity, false-negative rates, negative predictive value, and analysis of the distribution of pelvic and para-aortic sentinel lymph nodes. Results The rate of detection of at least one sentinel lymph node, sensitivity, and the negative predictive value was 80%, 66.6%, 96.6% for the cervical group and 85%, 66.6%, 96.9% for the endometrial group, respectively. False-negative sentinel lymph nodes were detected in one patient from each group . There was no significant difference between the groups in terms of total sentinel lymph node count, sentinel pelvic lymph node count, and pelvic bilaterality, but the para-aortic sentinel lymph node count was significantly higher in the endometrial group (p<0.001). Ultra-staging examination of the pelvic sentinel lymph nodes revealed isolated tumor cells in one patient from each group. Conclusion Transcervical endometrial tracer injection in endometrial cancer revealed similar pelvic but significantly higher para-aortic sentinel lymph node detection.

1 March 2024 in Journal of Gynecology Obstetrics and Human Reproduction
Verified
Journal Article
Closed access
GGGezer Gezer
Gezer Gezer
ADAyşe Seda Daryal
Ayşe Seda Daryal
LALale Aksoy
Lale Aksoy

1 September 2021 in Journal of Gynecology Obstetrics and Human Reproduction
Verified
Journal Article
Closed access
GGGezer Gezer
Gezer Gezer
APAlparslan Pulur
Alparslan Pulur
IYİzZet Yücesoy
İzZet Yücesoy


1 January 2021 in Northern Clinics of Istanbul
Verified
Journal Article
Open access
GGGezer Gezer
Gezer Gezer
SOSumeyye Kanbay Ozturk
Sumeyye Kanbay Ozturk
SBSibel Balci
Sibel Balci
IYIzzet Yucesoy
Izzet Yucesoy
OBJECTIVE: The objective of the study was to evaluate the concordance between colposcopic biopsy and loop electrosurgical excision procedure (LEEP) methods to diagnose cervical pre-invasive lesions and cervical cancer, and to calculate the low and high prediction rates of lesions for both methods. METHODS: A total of 241 patients who underwent LEEP after colposcopic biopsy for different indications and also known cervical cytology and human papillomavirus test results were included in the study. Clinical variables such as age, gravida, parity, menopausal status, smoking, endocervical curettage results, and surgical margins were recorded. RESULTS: The total concordance between colposcopic biopsy and LEEP was 41.9%. The rates of finding a more serious lesion than in colposcopic biopsy with LEEP (underestimation) for negative, Cervical Intraepithelial Neoplasia (CIN) 1, CIN 2, and CIN 3 were calculated as 100%, 12.8%, 14.8%, and 3.9%, respectively. Rates of finding a less serious lesion than detected in colposcopic biopsy with LEEP (overestimation) for CIN 1, CIN 2, and CIN 3, cervical carcinoma were calculated as 56.4%, 33.3%, 3.9%, and 0%, respectively. Underestimation was seen in a total of 28 patients, and overestimation was present in 113 patients. Parity was found to be the only associated factor that affected the final diagnosis for high-grade lesions in univariate logistic regression analysis (odds ratio=1.234, 95% confidence interval: 1.005-1.514). CONCLUSION: Discrepancies between colposcopically directed punch biopsy and subsequent histopathologic LEEP findings are common. New methods to reduce the inconsistency between colposcopic biopsy and LEEP are necessary to prevent patients from being under or over treated.